Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced ...
The review highlights the importance of understanding this gene's function to unravel new therapeutic targets. HSD17B13, primarily expressed in the liver, is associated with lipid metabolism within ...